Arcadia Biosciences Net Debt Over Time
| RKDA Stock | USD 2.74 0.15 5.79% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Arcadia Biosciences Performance and Arcadia Biosciences Correlation. Arcadia |
Is Agricultural Products & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arcadia Biosciences. If investors know Arcadia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arcadia Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.285 | Earnings Share (6.77) | Revenue Per Share 3.802 | Quarterly Revenue Growth (0.04) | Return On Assets (0.39) |
The market value of Arcadia Biosciences is measured differently than its book value, which is the value of Arcadia that is recorded on the company's balance sheet. Investors also form their own opinion of Arcadia Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Arcadia Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arcadia Biosciences' market value can be influenced by many factors that don't directly affect Arcadia Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arcadia Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Arcadia Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arcadia Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Net Debt Analysis
Compare Arcadia Biosciences and related stocks such as YanGuFang International, Better Choice, and Stryve Foods Net Debt Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BTTR | (3.2 K) | 30 K | 40 K | 68.1 K | 15.7 K | 38.5 K | 257.1 K | 632.3 K | (80.9 K) | 35.9 M | 29 M | (11.4 M) | 8.4 M | 291 K | 276.4 K |
| SNAX | 15.8 K | 15.8 K | 15.8 K | 15.8 K | 15.8 K | 15.8 K | 15.8 K | 22.1 K | 106.5 K | 20.4 M | 29.4 M | 13.1 M | 17.7 M | 23.6 M | 14.3 M |
| BTOG | 11.9 M | 11.9 M | 11.9 M | 11.9 M | 11.9 M | 11.9 M | 11.9 M | 10.1 M | 8.7 M | 16.8 M | 2.1 M | 1.7 M | 2.1 M | 1.9 M | 1.8 M |
| FAMI | 5.3 M | 5.3 M | 5.3 M | 5.3 M | 5.3 M | 3.9 M | (276.5 K) | (2.8 M) | 4.2 M | 5.6 M | (56.2 M) | (36.6 M) | (1.7 M) | (1.6 M) | (1.6 M) |
| LSF | (17.2 M) | (17.2 M) | (17.2 M) | (17.2 M) | (17.2 M) | (17.2 M) | (17.2 M) | (17.2 M) | (17.2 M) | (953.1 K) | (57.2 M) | (23 M) | (17.7 M) | (7.2 M) | (7.5 M) |
| PLAG | 26.4 M | 34.3 M | 27.7 M | 55.2 M | 75.4 M | 51.8 M | 52.2 M | 52.2 M | (1.1 M) | (6.9 M) | (3.4 M) | 6.5 M | 3.8 M | 3.4 M | 3.2 M |
| SENEA | 107.5 M | 224.8 M | 256.1 M | 216.9 M | 273.5 M | 312.6 M | 359.8 M | 444.7 M | 292.5 M | 301.8 M | 109.6 M | 167.2 M | 480.2 M | 639 M | 670.9 M |
| BRID | 700 K | (8 M) | (6.8 M) | 1.2 M | (5.1 M) | (6.4 M) | (11.7 M) | (8.2 M) | 10.7 M | 26.3 M | 39 M | (6.6 M) | (8.2 M) | (9.4 M) | (9.9 M) |
Arcadia Biosciences and related stocks such as YanGuFang International, Better Choice, and Stryve Foods Net Debt description
The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.My Equities
My Current Equities and Potential Positions
| Arcadia Biosciences | RKDA |
| Classification | Agriculture |
| Location | United States; U.S.A |
| Exchange | NASDAQ Exchange |
USD 2.74
Check out Arcadia Biosciences Performance and Arcadia Biosciences Correlation. For information on how to trade Arcadia Stock refer to our How to Trade Arcadia Stock guide.You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Arcadia Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.